| Predicate |
Object |
| contentType |
Journal Article |
| endingPage |
8; author reply 311 |
| issn |
1083-7159
1549-490X |
| issueIdentifier |
5 |
| pageRange |
306-8; author reply 311 |
| publicationName |
The Oncologist |
| startingPage |
306 |
| bibliographicCitation |
Balla J. The issue of renal safety of zoledronic acid from a nephrologist's point of view. Oncologist. 2005 May;10(5):306–8; author reply 311. doi: 10.1634/theoncologist.10-5-306. PMID: 15851781. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_51d2d8892a8868bdfb5010850b333bbe |
| date |
2005-05-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| identifier |
https://doi.org/10.1634/theoncologist.10-5-306
https://pubmed.ncbi.nlm.nih.gov/15851781 |
| isPartOf |
https://portal.issn.org/resource/ISSN/1549-490X
https://portal.issn.org/resource/ISSN/1083-7159
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/21392 |
| language |
English |
| source |
https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/ |
| title |
The Issue of Renal Safety of Zoledronic Acid from a Nephrologist's Point of View |
| discusses |
http://id.nlm.nih.gov/mesh/M0234600
http://id.nlm.nih.gov/mesh/M0197524
http://id.nlm.nih.gov/mesh/M0071565
http://id.nlm.nih.gov/mesh/M0001483
http://id.nlm.nih.gov/mesh/M0011048
http://id.nlm.nih.gov/mesh/M0006270
http://id.nlm.nih.gov/mesh/M0006519 |
| hasPrimarySubjectTerm |
http://id.nlm.nih.gov/mesh/D006934Q000188
http://id.nlm.nih.gov/mesh/D007093Q000008
http://id.nlm.nih.gov/mesh/D001859Q000188
http://id.nlm.nih.gov/mesh/D004164Q000008 |
| hasSubjectTerm |
http://id.nlm.nih.gov/mesh/D001859Q000150
http://id.nlm.nih.gov/mesh/D006934Q000209
http://id.nlm.nih.gov/mesh/D000077268
http://id.nlm.nih.gov/mesh/D013997
http://id.nlm.nih.gov/mesh/D000970Q000008
http://id.nlm.nih.gov/mesh/D007262
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D000077557
http://id.nlm.nih.gov/mesh/D000077211
http://id.nlm.nih.gov/mesh/D004002Q000008 |